July 4, 2017 M&A, Partnerships

Hitachi High-Technologies’ Stock Purchase (Subsidiary Acquisition) and Business Acquisition of Part of the Oxford Instruments plc Group and Overview of the New Company

(PDF format, 164kBytes) July 4, 2017 Tokyo, Japan, July 4, 2017 – Hitachi High-Technologies Corporation (TSE: 8036, Hitachi High-Tech) announced today that, as noted in the April 26, 2017 news release titled “Hitachi High-Technologies Enters Into an Agreement on the Stock Purchase (Subsidiary Acquisition) and Business Acquisition of Part of the Industrial Precision Instruments Business... Read more

July 4, 2017 M&A, Partnerships

Completion of Sale of Industrial Analysis business to Hitachi High-Technologies

03 July 2017 Completion of Sale of Industrial Analysis business to Hitachi High-Technologies Further to the announcement made on 26 April 2017, Oxford Instruments plc, a leading provider of high technology solutions, information and services for industry and research, today announces that it has completed the sale of its Industrial Analysis business to Hitachi High-Technologies... Read more

July 4, 2017 M&A, Partnerships

ImmunoPrecise To Acquire U-Protein and Announces $4,000,000 Financing

Victoria, British Columbia, Canada, July 4, 2017 – IMMUNOPRECISE ANTIBODIES (the “Company”) (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that it has signed a binding letter of intent with U-Protein Express BV (“U-Protein“) whereby the Company has agreed to acquire all of the issued and outstanding shares of U-Protein (the “Transaction”).  This represents a key step in the... Read more

July 4, 2017 Clinical Research/Diagn.

Roche launches the first fully automated CE marked HIV-1/HIV-2 qualitative diagnostic test on cobas® 6800/8800 Systems

July 4, 2017   Differentiates between HIV-1 and HIV-2 infections to confidently treat patients based on HIV subtype infection Significant reduction in time to detection is critical in curbing further disease transmission Access to testing in rural areas through validated dried blood spot (DBS) collection card Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial... Read more

July 3, 2017 Clinical Research/Diagn. Life Science Tools

Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections

Basel, 03 July 2017 Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections With more than 150,000 affected patients per year, MRSA and SA are major sources of healthcare and community associated infections in Europe Fast detection reduces the risk of transmission within the hospital, but classical... Read more

June 30, 2017 M&A, Partnerships

Precipio Diagnostics and Transgenomic Complete Merger

Company Renamed Precipio, Inc.–To Commence Trading On NASDAQ Under The New Ticker “PRPO” NEW HAVEN, Conn. and OMAHA, Neb., (June 30, 2017) – Precipio Diagnostics, LLC and Transgenomic Inc. (OTCQB: TBIOD) today announced the closing of their previously announced merger. In connection with the transaction, Transgenomic has changed its name to Precipio, Inc. Precipio’s common stock... Read more